EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IFN γ and TNF α drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer

Lilian Koppensteiner iD, Layla Mathieson, Liam Neilson, Richard A O'Connor, Ahsan R Akram iD

FEBS Letters · 2025-03 · 599 (5) · 713-723

DOI: 10.1002/1873-3468.15083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2025-01. Verfasst von Lilian Koppensteiner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, UK. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cancer-Associated Fibroblasts, Lung Neoplasms, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Cancer Research UK Clinician Scientist Fellowship, GSK Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐associated fibroblasts (CAFs) are the dominant nonmalignant component of the tumour microenvironment (TME). CAFs demonstrate a high level of inter‐ and intra‐tumour heterogeneity in solid tumours, though the drivers of CAF subpopulations are not fully understood. Here, we demonstrate that non‐small cell lung cancer (NSCLC) patient‐derived CAFs upregulate the secretion of inflammatory cytokines (IL6, LIF, IL33, GM‐CSF, IL1ra) and chemokines (CCL2, CCL3, CCL4, CCL20, CXCL8, CXCL9, CXCL10, CXCL11) in response to in vitro co‐culture with anti‐CD3/anti‐CD28‐stimulated peripheral blood mononuclear cells (PBMCs) via IFNγ and TNFα. Furthermore, T‐cell‐derived IFNγ inhibits CXCL12 secretion by CAFs in vitro . Our results highlight the ability of T‐cell effector cytokines to modulate the CAF secretome in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCancer-Associated FibroblastsLung NeoplasmsTumor Necrosis Factor-alphaInterferon-gammaHumansTumor MicroenvironmentCoculture TechniquesCell Line, TumorLeukocytes, MononuclearInflammationCytokines

Stichwörter der Autor:innen

cancer‐associated fibroblastinterferon‐licenced fibroblastnon‐small cell lung cancersecretometumour microenvironment

Substanzen

Tumor Necrosis Factor-alphaInterferon-gammaCytokines

Autor:innen und Institutionen

  • Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, UK.
  • Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, UK.

ORCID-Profile: Lilian Koppensteiner, Ahsan R Akram

Förderung

  • Cancer Research UK
  • Cancer Research UK Clinician Scientist Fellowship
  • GSK Funding

Zitieren

APA

Koppensteiner, L., Mathieson, L., Neilson, L., O'Connor, R. A., & Akram, A. R. (2025). IFN γ and TNF α drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer. FEBS Letters, 599(5), 713-723. https://doi.org/10.1002/1873-3468.15083

Vancouver

Koppensteiner L, Mathieson L, Neilson L, O'Connor RA, Akram AR. IFN γ and TNF α drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer. FEBS Letters. 2025;599(5):713-723. doi:10.1002/1873-3468.15083

BibTeX
@article{Koppensteiner2025,
  author = {Koppensteiner, Lilian and Mathieson, Layla and Neilson, Liam and O'Connor, Richard A and Akram, Ahsan R},
  title = {IFN γ and TNF α drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer},
  journal = {FEBS Letters},
  year = {2025},
  volume = {599},
  number = {5},
  pages = {713--723},
  doi = {10.1002/1873-3468.15083}
}
Kostenlos starten →